In vitro and in vivo studies displayed that ANRIL overexpression sustains MM cell growth and resistance to bortezomib-induced apoptosis by interacting with the histone-methyltransferase enzyme EZH2 that epigenetically silences PTEN and mediates chemoresistance [124]. The gene discussed is PTEN; the disease is Miyoshi myopathy.